Position in KOD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,636,501
+$1,902,072 QoQ
Shares Held
67,672
-34.0% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#64
of 200 holders
Holding Since
Sep 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KOD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $280,525,216 across 101 Biotechnology names. KOD ranks #37 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in KOD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,636,501 | 67,672 | Shares | Sole | 2026-08-14 | |
| 2022-12-31 | $734,429 | 102,574 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,100,721 | 271,411 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $144,632 | 18,931 | Shares | Other | 2022-08-22 | |
| 2022-03-31 | $630,052 | 81,613 | Shares | Sole | 2022-05-13 | |
| 2020-12-31 | $721,475 | 4,911 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $685,947 | 11,585 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||